Uneventful propofol anaesthesia in a patient with acute intermittent porphyria

European Journal of Anaesthesiology

Volumn 16, Issue 7, 1999, Pages 485-492

  Pazvanska, E E ^a   Hinkov, O D ^a   Stojnovska, L V ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Anaesthetics, intravenous, propofol; Complications, porphyria

Indexed keywords

PORPHYRIN; PROPOFOL;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CLINICAL FEATURE; FEMALE; GENERAL ANESTHESIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; URINE LEVEL;

ADULT; ANESTHETICS, INTRAVENOUS; CHOLECYSTECTOMY; FEMALE; FENTANYL; FOLLOW-UP STUDIES; HUMANS; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRINS; PROPOFOL;

EID: 0032764844     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.1999.00509.x     Document Type: Article

References (55)

1. Elder GH, Path FRC. Enzymatic defects in porphyria: an overview. Semin Liver Dis 1982; 2: 87-99.
2. Böhrer H, Schmidt H, Martin E, Lux R, Bolsen K, Goerz G. Testing the porphyrinogenicity of propofol in a primed rat model. Br J Anaesth 1995; 75: 334-338.
3. Moore MR, McColl KEL, Rimington C, Goldberg A. Disorders of Haem Metabolism. New York and London: Plenum Medical Book Company, 1987.
4. Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995; 80: 591-599.
5. Sassa S. ALAD porphyria. Semin Liver Dis 1998; 18: 95-101.
6. Gorchein A. Drug treatment in acute porphyria. Br J Clin Pharmacol 1997; 44: 427-434.
7. Moore MR, Hift RJ. Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol (Noisy le Grand) 1997; 43: 89-94.
8. Floderus Y, Harper P, Henrichson A, Thunell Sandersson D. Prevention of acute intermittent porphyria is the best solution. Most important are early diagnosis and counselling. Lakartidningen 1998; 95: 3045-3050.
9. Harrison GG, Meissner PN, Hift RJ. Anaesthesia for the porphyric patient. Anaesthesia 1993; 48: 417-422.
10. Yeung Laiwah AC, McColl KEL. Management of attacks of acute porphyria. Drugs 1987; 34: 604-616.
11. Harrison GG, Moore MR, Meissner PN. Porphyrinogenicity of etomidate and ketamine as continuous infusions. Screening in the DDC-primed rat model. Br J Anaesth 1985; 57: 420-423.
12. Famewo CE. Induction of anaesthesia with etomidate in a patient with acute intermittent porphyria. Can Anaesth Soc J 1985; 32: 171-173.
13. Buzaleh A, De Salamanca RC, Battle A. Porphyrinogenic properties of the anesthetic enflurane. Gen Pharmacol 1992; 23: 665-669.
14. Bonkovsky HL, Schady W. Neurologic manifestations of acute porphyria. Semin Liver Dis 1982; 2: 108-124.
15. Eales L. Porphyria and the dangerous life-threatening drugs. S Afr Med J 1979; 56: 914-917.
16. Dundee JW, McCleery WNC, McLoughlin G. The hazard of thiopental anesthesia in porphyria. Anesth Analg 1962; 41: 567-574.
17. Ashley EM. Anaesthesia for porphyria. Br J Hosp Med 1996; 56: 37-42.
18. Blanloeil Y. Porphyries hépatiques aiguës et 'Diprivan'. Ann Fr Anesth Réanim 1994; 13: 485-489.
19. Blanloeil Y, Deybach JC, Portier D, Joyau M, Nordmann Y. Anesthésie et porphyries hépatiques. Ann Fr Anesth Réanim 1989; 8: 109-125.
20. Parikh RK, Moore MR. A comparison of the porphyrinogenicity of di-isopropylphenol (propofol) and phenobarbitone. Biochem Soc Transac 1986; 14: 726-727.
21. Mitterschiffthaler G, Theiner A, Hetzel H, Fuith LC. Safe use of propofol in a patient with acute intermittent porphyria. Br J Anaesth 1988; 60: 109-111.
22. Meissner PN, Harrison GG, Hift RJ. Propofol as an i.v. anaesthetic induction agent in variegate porphyria. Br J Anaesth 1991; 66: 60-65.
23. Kasraie N, Cousins TB. Propofol and the patient with hereditary coproporphyria. Anesth Analg 1993; 77: 862-863.
24. Glen JB. The pharmacology and pharmacokinetics of 'Diprivan'. Acta Anaesthesiol Scand 1987; 31 (Suppl. 86): A76.
25. Buehrer M, Bigler P. Why not simply use barbiturates for the induction of general anaesthesia? Curr Opin Anaesthesiol 1992; 5: 505-508.
26. Harrison G. Propofol anaesthesia in pharmacogenetic states. In: Prys-Roberts C, ed. Focus on Infusion: Intravenous Anaesthesia Proceedings of Symposium on Intravenous Anaesthesia Cannes, 1991: 186-190.
27. Boehrer H, Schmidt H, Augenstein T, Lux R, Bolsen K, Goerz G. Porphyrinogenicity and metabolic effects of propofol in an AIA-primed rat model. Eur J Anaesthesiol 1991; 8: 486.
28. Gorchein A. Porphyria, propofol and rats. (Letter) Br J Anaesth 1996; 76: 172.
29. Tidmarsh MD. Porphyria, propofol and rats. (Letter) Br J Anaesth 1996; 76: 171-172.
30. Mustajoki P, Heinonen J. General anesthesia in 'inducible' porphyrias. Anesthesiology 1980; 53: 15-20.
31. Thunell S, Andersson D, Harper P, Henrichson A, Floderus Y, Lindh U. Effects of administration of antioxidants in acute intermittent porphyria. Eur J Clin Chem Clin Biochem 1997; 35: 427-433.
32. Murphy PG, Davies MJ, Columb MO. Effect of propofol and thiopentone on free radical mediated oxidative stress of the erythrocyte. Br J Anaesth 1996; 76: 536-543.
33. Stratford NJ, Murphy PG. Effect of lipid and propofol on oxidation of haemoglobin by reactive oxygen species. Br J Anaesth 1997; 78: 320-322.
34. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68: 613-618.
35. Navapurkar VU, Menon DK, Jones JG. Propofol protects rat hepatocytes against an oxidant stress. Br J Anaesth 1996; 77: 691.
36. Lanza V, Guglielmo L. Propofol en perfusion continue chez une patiente atteinte d'une porphyrie aiguë intermittente. Ann Fr Anesth Réanim 1992; 11: 604.
37. Richard T, Haberer JP. Utilisation du propofol (Diprivan) chez une patiente présentant une porphyrie aiguë intermittente (Lettre). Ann Fr Anesth Réanim 1988; 7: 442.
38. Kantor G, Rolbin SH. Acute intermittent porphyria and Caesarean delivery. Can J Anaesth 1992; 39: 282-285.
39. Cooper R. Anaesthesia for porphyria using propofol. Anaesthesia 1988; 43: 611.
40. Elcock D, Norris A. Elevated porphyrins following propofol anaesthesia in acute intermittent porphyria. Anaesthesia 1994; 49: 957-958.
41. Shaw IH, McKeith IG. Propofol and electroconvulsive therapy in a patient at risk from acute intermittent porphyria. Br J Anaesth 1998; 80: 260-262.
42. Stevens JJWM, Kneeshaw JD. Mitral valve replacement in a patient with acute intermittent porphyria. Anesth Analg 1996; 82: 416-418.
43. Tidmarsh MA, Baigent DF. Propofol in acute intermittent porphyria. Br J Anaesth 1992; 68: 230.
44. Parr MJA, Hayden Smith J. Propofol, porphyria and epilepsy. Anaesthesia 1990; 45: 594.
45. Harrison JC, McAuley FT. Propofol for sedation in intensive care in a patient with an acute porphyric attack. Anaesthesia 1992; 47: 355-356.
46. Kroh UF, Frank M, Schwerk C, Doss MO. Anaesthesie mit Propofol bei einem exazerbierten Verlauf der acuten intermittierenden Porphyrie. Anaesthesiol Intensivmed Notfallmed Schmerzther 1993; 28: 531-533.
47. Rigg J, Petts V. Acute porphyria and propofol (Letter). Anaesthesia 1993; 48: 1108.
48. Rushman GB, Jooste CA, Rigg JD, Petts V. Anaesthesia for the porphyric patient. Anaesthesia 1993; 48: 1009-1010.
49. Weir PM, Hodkinson BP. Is propofol a safe agent in porphyria ? Anaesthesia 1988; 43: 1022-1023.
50. Hughes PJ. Propofol in acute porphyrias. Anaesthesia 1990; 45: 415.
51. Boehrer H. Porphyria, propofol and rats. (Letter) Br J Anesth 1996; 76: 172.
52. Boehrer H, Schmidt H, Motsch J, Kasraie N. Propofol and the patient with hereditary coproporphyria. Anesth Analg 1994; 78: 1200-1201.
53. Disler PB, Eales L. The acute attack of porphyria. S Afr Med J 1982; 61: 82-84.
54. Christian AS. Safe use of propofol in a child with acute intermittent porphyria. Anaesthesia 1991; 46: 423-424.
55. Garcia Galan F, Pensado A, Luengo A, Roca E, Cabrero Y. Management of propofol anaesthesia in a case of tardive cutaneous porphyria. Rev Esp Anestesiol Reanim 1994; 41: 124-125.